Newamsterdam Pharma Company N.V. (NAMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NAMS | INDV | ORKA | ||
| Company | Newamsterdam Pharma Company N.V. | Indivior Pharmaceuticals Inc | Oruka Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 34.59 | 33.00 | 67.45 | ||
| High | 34.75 | 33.62 | 67.94 | ||
| Low | 33.26 | 32.13 | 64.88 | ||
| Latest | 34.01 | 32.52 | 65.55 | ||
| Change | -0.43 | -0.45 | -1.51 | ||
| % Change | -1.25% | -1.36% | -2.25% | ||
| Volume | 742,700 | 1,389,600 | 1,402,900 | ||
| 20-Day Average Volume | 867,610 | 2,477,505 | 1,149,975 | ||
| Previous Close | 34.44 | 32.97 | 67.06 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 32.24 | 30.54 | 51.41 | ||
| 20-Day Raw Stochastic | 65.66% | 81.48% | 92.14% | ||
| 20-Day Relative Strength | 53.71 | 53.64 | 74.49 | ||
| Weighted Alpha | +84.18 | +173.45 | +592.25 | ||
| Today's Opinion | 40% Buy | 32% Buy | 100% Buy | ||
| Previous Opinion | 40% Buy | 32% Buy | 100% Buy | ||
| Last Month's Opinion | 24% Sell | 8% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | unch since 04/08/26 | +1.82% since 04/08/26 | +5.71% since 04/08/26 | ||
| Low | 33.26 on 04/15/26 | 30.11 on 04/13/26 | 59.00 on 04/10/26 | ||
| High | 36.73 on 04/14/26 | 33.62 on 04/15/26 | 67.94 on 04/15/26 | ||
| 1-Month | |||||
| %Chg | +18.83% since 03/13/26 | +4.53% since 03/13/26 | +63.88% since 03/13/26 | ||
| Low | 28.71 on 03/16/26 | 27.68 on 03/24/26 | 37.55 on 03/20/26 | ||
| High | 36.73 on 04/14/26 | 33.62 on 04/15/26 | 67.94 on 04/15/26 | ||
| 3-Month | |||||
| %Chg | +6.85% since 01/15/26 | -1.11% since 01/15/26 | +101.69% since 01/15/26 | ||
| Low | 28.53 on 03/13/26 | 27.68 on 03/24/26 | 31.00 on 02/11/26 | ||
| High | 37.76 on 02/18/26 | 36.03 on 02/02/26 | 67.94 on 04/15/26 | ||
| 6-Month | |||||
| %Chg | -15.92% since 10/15/25 | +29.10% since 10/15/25 | +134.86% since 10/15/25 | ||
| Low | 28.53 on 03/13/26 | 23.72 on 10/20/25 | 25.11 on 10/22/25 | ||
| High | 42.00 on 11/26/25 | 38.00 on 12/08/25 | 67.94 on 04/15/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,959,739 | 4,019,768 | 3,322,353 | ||
| Shares Outstanding, K | 114,975 | 121,922 | 49,543 | ||
| Annual Sales | 22,500,000 | 1,239,000,000 | 0 | ||
| Annual Net Income | -203,820,000 | 210,000,000 | -105,430,000 | ||
| Last Quarter Sales | 30,000 | 357,000,000 | 0 | ||
| Last Quarter Net Income | -74,920,000 | 103,000,000 | -29,580,000 | ||
| 60-Month Beta | 0.13 | 0.88 | -0.54 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.63 on 02/18/26 | 0.82 on 02/26/26 | -0.45 on 03/12/26 | ||
| Latest Earnings Date | 05/14/26 | 04/30/26 | 05/13/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 12.85 | 0.00 | ||